1-207899084-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001025109.2(CD34):c.405G>T(p.Lys135Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000681 in 1,614,224 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001025109.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD34 | ENST00000310833.12 | c.405G>T | p.Lys135Asn | missense_variant | 3/8 | 1 | NM_001025109.2 | ENSP00000310036.7 | ||
CD34 | ENST00000356522.4 | c.405G>T | p.Lys135Asn | missense_variant | 3/8 | 1 | ENSP00000348916.4 | |||
CD34 | ENST00000485761.1 | n.51G>T | non_coding_transcript_exon_variant | 1/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000127 AC: 32AN: 251494Hom.: 0 AF XY: 0.0000956 AC XY: 13AN XY: 135922
GnomAD4 exome AF: 0.0000643 AC: 94AN: 1461884Hom.: 0 Cov.: 33 AF XY: 0.0000674 AC XY: 49AN XY: 727246
GnomAD4 genome AF: 0.000105 AC: 16AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.405G>T (p.K135N) alteration is located in exon 3 (coding exon 3) of the CD34 gene. This alteration results from a G to T substitution at nucleotide position 405, causing the lysine (K) at amino acid position 135 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at